Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination.

Jarrah, Kawthar; Al Mahmasani, Layal; Atoui, Ali; Bou-Fakhredin, Rayan; Taher, Ali T

Jarrah, Kawthar; Al Mahmasani, Layal; Atoui, Ali; Bou-Fakhredin, Rayan; Taher, Ali T.

Afiliação

Jarrah K; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Al Mahmasani L; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Atoui A; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Bou-Fakhredin R; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Taher AT; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.

Blood Cells Mol Dis ; 93: 102641, 2022 03.

Article em En | MEDLINE | ID: mdl-34980554

Assuntos

Vacina BNT162/efeitos adversos; COVID-19/prevenção & controle; Hemoglobinúria Paroxística/etiologia; Adulto; Vacina BNT162/uso terapêutico; COVID-19/imunologia; Ativação do Complemento; Feminino; Hemoglobinúria Paroxística/diagnóstico; Hemoglobinúria Paroxística/imunologia; Hemólise; Humanos

Palavras-chave

COVID-19; Paroxysmal nocturnal hemoglobinuria; Vaccine; mRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 / Hemoglobinúria Paroxística Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Blood Cells Mol Dis Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google